COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 740

Article download: 344

Indian Journal of Clinical and Experimental Ophthalmology

The role of Rebamipide ophthalmic suspension in management of dry eye disease

Full Text PDF Share on Facebook Share on Twitter

Author Details : Laxmi Dorennavar, Rajendra P Maurya, Virendra P Singh, Mahendra K Singh, Kamya Sharma, Ritika Sharma

Volume : 1, Issue : 4, Year : 2015

Article Page : 191-196

Suggest article by email


Purpose of review: Review of the drug Rebamipide, an ophthalmic suspension, in the treatment of dry eye and other ocular surface disorders.
Method: An extensive literature search was done on articles published in various ophthalmic journals to review the work on the latest drug rebamipide and its role in treating dry eye and other ocular surface disorders.
Recent Findings: Rebamipide is a novel drug for the treatment of dry eye disorders. It is a mucin-secretogogue, has a cytoprotective, anti-inflammatory effect and also suppresses the detrimental oxygen free radicals and helps in faster healing of epithelium. No major side effect has been noticed apart from dysguesia.
Summary: Rebamipide is the latest drug introduced in the treatment of dry eye. It seems to be a safe and effective treatment in   chronic and severe forms of dry eye particularly due to mucus deficiency.

Key Words:
Dry eye, Goblet cell, Microvilli, Rebamipide, Tear film

How to cite : Dorennavar L, Maurya R P, Singh V P, Singh M K, Sharma K, Sharma R, The role of Rebamipide ophthalmic suspension in management of dry eye disease. Indian J Clin Exp Ophthalmol 2015;1(4):191-196

Copyright © 2015 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (